Sirna CFO Schmeig signs off
Adjust font size:
Manufacturing News, Source : TheManufacturer.com
Published : 30 Mar 2005 22:59
Biotechnology company Sirna Therapeutics today announced that Martin E. Schmieg, its senior vice president and chief financial officer, has resigned his position, effective April 22.
Patti Ketchner, currently VP and corporate controller, will resume day-to-day financial management responsibilities for the company in the interim between Schmieg's departure and the naming of his replacement. In addition, during this interim period, Rebecca Galler Robison will assume day-to-day responsibilities for the company's investor relations function. Robison has served as Sirna's senior director of corporate strategy since January 2005.
For the past several years, I have been working away from my family and home in Philadelphia, and I have decided to pursue a business opportunity closer to home, said Schmieg in a statement.
Sirna Therapeutics is a clinical-stage biotechnology company developing therapies for many diseases and conditions, including age-related macular degeneration, Huntington's disease, diabetes, asthma, oncology, and hepatitis C. The company has strategic partnerships with pharmaceutical giant Eli Lilly and Company, Targeted Genetics and Archemix.
Comments on this story
click here to add a comment
You must be registered & logged in to add comments
already have an account and just want to login?
Related Content
Guest Editorial: Checklist - Seven Recommendations for Improved Profits
by Abbott A. Imberman, PhD, Professor of...
more…
FKI LOGISTEX OPENS NORTH AMERICAN TECHNOLOGY & EDUCATION CENTER (TEC)
(St. Louis, Missouri, USA: July 10, 2007) FKI...
more…
Guess selects the tradecard platformand SourceView suite to optimize global trade
NEW YORK, July 10, 2007 TradeCard Inc., the...
more…
Kimberly-Clark Professional Crosses Final Touchless Frontier With Introduction of First Electronic Bath Tissue Dispenser
ROSWELL, Ga. (July 9, 2007) Kimberly-Clark...
more…
Boeing Celebrates the Premiere of the 787 Dreamliner
EVERETT, Wash., July 08, 2007 -- Today, Boeing...
more…
no comments yet...